You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華檢醫療(01931.HK)料中期少賺逾73% 擬赴美雙重主要上市
阿思達克 07-15 09:16
華檢醫療(01931.HK)發盈警,預期截至2025年6月30日止六個月純利將錄得最少3,300萬元人民幣(下同),較去年同期的約1.25億元下跌約73.6%,主要由於期內勞工成本上升導致行政開支增加,以及公司向一家以化學發光技術和產品為核心的體外診斷企業支付技術服務費,令銷售及分銷開支上升。 另外,華檢醫療宣布,計劃在美國納斯達克市場通過首次公開發售美國存託股份(ADS)方式進行雙重主要上市,預期有助建立美國公開市場、擴大股東基礎及融資渠道,提升國際資本市場形象及證券流動性。目前雙重主要上市計劃尚處早期階段,需獲得香港及美國監管機構批准、滿足相關條件,並視市場狀況方可落實。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account